Chunhua Ling

864 total citations
45 papers, 658 citations indexed

About

Chunhua Ling is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chunhua Ling has authored 45 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chunhua Ling's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (6 papers). Chunhua Ling is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (6 papers). Chunhua Ling collaborates with scholars based in China, United States and Canada. Chunhua Ling's co-authors include Xiaochen Wang, Jun Zhao, Zeyi Liu, Min Jiang, Limin Yang, Shaomu Chen, Ning Xu, Yufeng Liu, Haicheng Tang and Yan Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Medicine.

In The Last Decade

Chunhua Ling

43 papers receiving 646 citations

Peers

Chunhua Ling
Yeyang Xu China
Chunhua Ling
Citations per year, relative to Chunhua Ling Chunhua Ling (= 1×) peers Yeyang Xu

Countries citing papers authored by Chunhua Ling

Since Specialization
Citations

This map shows the geographic impact of Chunhua Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunhua Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunhua Ling more than expected).

Fields of papers citing papers by Chunhua Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunhua Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunhua Ling. The network helps show where Chunhua Ling may publish in the future.

Co-authorship network of co-authors of Chunhua Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Chunhua Ling. A scholar is included among the top collaborators of Chunhua Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunhua Ling. Chunhua Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Di, Wenjuan, Haotian Xu, Chunhua Ling, & Ting Xue. (2023). Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model. Thrombosis Journal. 21(1). 95–95. 7 indexed citations
2.
Liu, Xinxin, Xingzhi Liu, Lin Wang, et al.. (2022). Piezo1-targeted aerosol inhalation nanoparticles for acute lung injury. Journal of Material Science and Technology. 141. 21–31. 9 indexed citations
3.
Zhang, Weili, et al.. (2022). MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells. Genetic Testing and Molecular Biomarkers. 26(7-8). 351–359. 2 indexed citations
4.
Zhang, Weili, et al.. (2022). LINC00116 Is a Novel Prognostic Biomarker of Nonsmall Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 26(6). 340–347. 1 indexed citations
5.
Song, Shu, Haicheng Tang, Wenqiang Quan, Anquan Shang, & Chunhua Ling. (2022). Estradiol initiates the immune escape of non-small cell lung cancer cells via ERβ/SIRT1/FOXO3a/PD-L1 axis. International Immunopharmacology. 107. 108629–108629. 19 indexed citations
6.
Chen, Bo & Chunhua Ling. (2021). Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Xiong, Feng, Hong Yin, Hui Zhang, et al.. (2019). Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA HOTAIRM1 in Non-Small Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 24(1). 47–53. 7 indexed citations
8.
Ling, Chunhua, et al.. (2019). Curcumin ameliorates chronic obstructive pulmonary disease by modulating autophagy and endoplasmic reticulum stress through regulation of SIRT1 in a rat model. Journal of International Medical Research. 47(10). 4764–4774. 37 indexed citations
9.
Ling, Chunhua, et al.. (2018). Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine. 16(6). 4578–4584. 2 indexed citations
10.
Chen, Bin, et al.. (2018). PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation. Journal of Cancer. 9(9). 1689–1697. 3 indexed citations
11.
Zhang, Yu, et al.. (2018). HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis. Biotechnology Letters. 40(4). 623–631. 28 indexed citations
13.
Xu, Ning, Shaomu Chen, Yufeng Liu, et al.. (2018). Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells. Cellular Physiology and Biochemistry. 48(5). 2046–2060. 62 indexed citations
14.
Yang, Limin, et al.. (2017). RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis. Biotechnology Letters. 40(3). 543–550. 18 indexed citations
15.
Tang, Peijun, Xia-Fang Wang, Xinghua Shen, et al.. (2017). Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid. Experimental and Therapeutic Medicine. 13(5). 2332–2338. 8 indexed citations
16.
Ling, Chunhua. (2012). Combination therapy in pulmonary arterial hypertension:a meta-analysis. 3 indexed citations
17.
Ling, Chunhua, Guodong Chen, Zubin Zhang, et al.. (2012). A deuterated analog of dasatinib disrupts cell cycle progression and displays anti‐non‐small cell lung cancer activity in vitro and in vivo. International Journal of Cancer. 131(10). 2411–2419. 26 indexed citations
18.
Ling, Chunhua, et al.. (2011). [The in vitro and in vivo effects of adenovirus-mediated inhibitor of growth 4 and interleukin-24 co-expression on the radiosensitivity of human lung adenocarcinoma].. PubMed. 34(6). 413–8. 2 indexed citations
19.
Chen, Yanbin, Ling Yang, Feng Wei, et al.. (2010). Angiosarcoma of the lung: 2 cases report and literature reviewed. Lung Cancer. 70(3). 352–356. 31 indexed citations
20.
Wang, Xiaochen, et al.. (2010). MicroRNA‐206 Is Associated With Invasion and Metastasis of Lung Cancer. The Anatomical Record. 294(1). 88–92. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026